Clinical trials
Terminated trials in Switzerland with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
224 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 7 |
| 2012 | 9 |
| 2013 | 17 |
| 2014 | 10 |
| 2015 | 11 |
| 2016 | 22 |
| 2017 | 24 |
| 2018 | 17 |
| 2019 | 11 |
| 2020 | 17 |
| 2021 | 18 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 224 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insel Gruppe AG, University Hospital Bern | 34 |
| University of Zurich | 17 |
| University Hospital, Geneva | 13 |
| University Hospital, Basel, Switzerland | 7 |
| University of Lausanne Hospitals | 7 |
| Centre Hospitalier Universitaire Vaudois | 6 |
| Abbott Medical Devices | 4 |
| Balgrist University Hospital | 4 |
| Cantonal Hospital of St. Gallen | 4 |
| University of Bern | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 9 |
| Heart Failure | 7 |
| Cardiovascular Diseases | 6 |
| Neoplasms | 6 |
| Coronary Artery Disease | 5 |
| Atrial Fibrillation | 4 |
| Breast Neoplasms | 4 |
| Hearing Loss | 4 |
| Heart Diseases | 4 |
| Parkinson Disease | 4 |
Trials
Showing 1 to 25 of 224. Each trial links to its page on Pharma Observatory.
124 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.